Abstract
Colorectal carcinoma (CRC) is the 3rd most common cancer worldwide, thus development of novel therapeutic strategies is imperative. Herein potent, selective dose-dependent antitumor activity of horse spleen apoferritin encapsulated PbS quantum dots (AFt-PbS) against two human-derived colorectal carcinoma cell lines is reported (GI50 ∼ 70 μg mL-1). Following in vitro exposure to AFt-PbS, CRC cells fail to recover proliferative capacity, and undergo apoptosis triggered by the generation of reactive oxygen species (ROS). In stark contrast, the AFt-PbS nanocomposites do not affect the growth and cell cycle of non-tumor human microvessel endothelial HMEC-1 cells (GI50 > 500 μg mL -1). In vivo, AFt-PbS QDs are well tolerated by mice. Neither adverse health nor behavioral indicators were observed throughout the 15 day study. The photoluminescence of AFt-PbS combined with selective antitumor activity offer potential development of AFt-PbS for simultaneous non-invasive imaging and treatment of malignant tissue. This journal is
| Original language | English |
|---|---|
| Pages (from-to) | 6254-6260 |
| Number of pages | 7 |
| Journal | Journal of Materials Chemistry B |
| Volume | 1 |
| Issue number | 45 |
| DOIs | |
| Publication status | Published - 7 Dec 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Groups and Themes
- Bristol BioDesign Institute
- Inorganic & Materials
Keywords
- synthetic biology
Fingerprint
Dive into the research topics of 'Apoferritin-encapsulated PbS quantum dots significantly inhibit growth of colorectal carcinoma cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver